| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.05 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.097 | 0.05 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.05 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.05 |